 |
Previous Article | Next Article 
The Journal of Neuroscience, December 1, 2000, 20(23):8677-8684
Dopamine D3 Receptors Expressed by All
Mesencephalic Dopamine Neurons
Jorge
Diaz1,
Catherine
Pilon2,
Bernard
Le
Foll2,
Claude
Gros2,
Antoine
Triller3,
Jean-Charles
Schwartz2, and
Pierre
Sokoloff2
1 Laboratoire de Physiologie, Université
René Descartes, 75006 Paris, France, 2 Unité de
Neurobiologie et Pharmacologie Moléculaire (Institut National de
la Santé et de la Recherche Médicale U 109), Centre Paul
Broca, 75014 Paris, France, and 3 Biologie Cellulaire de la
Synapse Normale et Pathologique (Institut National de la Santé et
de la Recherche Médicale U 497), Ecole Normale Supérieure,
75230 Paris, France
A polyclonal antibody was generated using synthetic peptides
designed in a specific sequence of the rat D3 receptor
(D3R). Using transfected cells expressing recombinant
D3R, but not D2 receptor, this antibody labeled
45-80 kDa species in Western blot analysis, immunoprecipitated a
soluble fraction of [125I]iodosulpride binding,
and generated immunofluorescence, mainly in the cytoplasmic perinuclear
region of the cells. In rat brain, the distribution of immunoreactivity
matched that of D3R binding, revealed using
[125I]R(+)trans-7-hydroxy-2-[N-propyl-N-(3'-iodo-2'-propenyl)amino] tetralin ([125I]7-trans-OH-PIPAT),
with dense signals in the islands of Calleja and mammillary bodies, and
moderate to low signals in the shell of nucleus accumbens (AccSh),
frontoparietal cortex, substantia nigra (SN), ventral tegmental area
(VTA) and lobules 9 and 10 of the cerebellum. Very low or no signals
could be detected in other rat brain regions, including dorsal
striatum, or in D3R-deficient mouse brain. Labeling of
perikarya of AccSh and SN/VTA appeared with a characteristic punctuate
distribution, mostly at the plasma membrane where it was not associated
with synaptic boutons, as revealed by synaptophysin immunoreactivity.
In SN/VTA, D3R immunoreactivity was found on afferent
terminals, arising from AccSh, in which destruction of intrinsic
neurons by kainate infusions produced a loss of D3R binding
in both AccSh and SN/VTA. D3R-immunoreactivity was also
found in all tyrosine hydroxylase (TH)-positive neurons observed in SN,
VTA and A8 retrorubral fields, where it could represent D3
autoreceptors controlling dopamine neuron activities, in agreement with
the elevated dopamine extracellular levels in projection areas of these
neurons found in D3R-deficient mice.
Key words:
nucleus accumbens shell; substantia nigra; ventral
tegmental area; D3 receptor-deficient mice; tyrosine
hydroxylase; synaptophysin
Copyright © 2000 Society for Neuroscience 0270-6474/00/20238677-08$05.00/0
This article has been cited by other articles:

|
 |

|
 |
 
D. H. Zald, R. L. Cowan, P. Riccardi, R. M. Baldwin, M. S. Ansari, R. Li, E. S. Shelby, C. E. Smith, M. McHugo, and R. M. Kessler
Midbrain Dopamine Receptor Availability Is Inversely Associated with Novelty-Seeking Traits in Humans
J. Neurosci.,
December 31, 2008;
28(53):
14372 - 14378.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Pan, C. J. Hillard, and Q.-s. Liu
D2 Dopamine Receptor Activation Facilitates Endocannabinoid-Mediated Long-Term Synaptic Depression of GABAergic Synaptic Transmission in Midbrain Dopamine Neurons via cAMP-Protein Kinase A Signaling
J. Neurosci.,
December 24, 2008;
28(52):
14018 - 14030.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Koyanagi, S. Himukashi, K. Mukaida, T. Shichino, and K. Fukuda
Dopamine D2-Like Receptor in the Nucleus Accumbens Is Involved in the Antinociceptive Effect of Nitrous Oxide
Anesth. Analg.,
June 1, 2008;
106(6):
1904 - 1909.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Vandecasteele, J. Glowinski, J.-M. Deniau, and L. Venance
Chemical transmission between dopaminergic neuron pairs
PNAS,
March 25, 2008;
105(12):
4904 - 4909.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Van Kampen and C. B. Eckman
Dopamine D3 receptor agonist delivery to a model of Parkinson's disease restores the nigrostriatal pathway and improves locomotor behavior.
J. Neurosci.,
July 5, 2006;
26(27):
7272 - 7280.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Chen, J. T. Kittler, S. J. Moss, and Z. Yan
Dopamine D3 Receptors Regulate GABAA Receptor Function through a Phospho-Dependent Endocytosis Mechanism in Nucleus Accumbens
J. Neurosci.,
March 1, 2006;
26(9):
2513 - 2521.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Jeanblanc, D.-Y. He, N. N. H. McGough, M. L. Logrip, K. Phamluong, P. H. Janak, and D. Ron
The Dopamine D3 Receptor Is Part of a Homeostatic Pathway Regulating Ethanol Consumption
J. Neurosci.,
February 1, 2006;
26(5):
1457 - 1464.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K.-M. Kim, R. R. Gainetdinov, S. A. Laporte, M. G. Caron, and L. S. Barak
G Protein-coupled Receptor Kinase Regulates Dopamine D3 Receptor Signaling by Modulating the Stability of a Receptor-Filamin-{beta}-Arrestin Complex: A CASE OF AUTORECEPTOR REGULATION
J. Biol. Chem.,
April 1, 2005;
280(13):
12774 - 12780.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Le Foll and S. R. Goldberg
Cannabinoid CB1 Receptor Antagonists as Promising New Medications for Drug Dependence
J. Pharmacol. Exp. Ther.,
March 1, 2005;
312(3):
875 - 883.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Nurnberger, M. Rabiger, A. Mack, J. Diaz, P. Sokoloff, B. Muhlbauer, and G. Luippold
Subapical Localization of the Dopamine D3 Receptor in Proximal Tubules of the Rat Kidney
J. Histochem. Cytochem.,
December 1, 2004;
52(12):
1647 - 1655.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Jeanneteau, O. Guillin, J. Diaz, N. Griffon, and P. Sokoloff
GIPC Recruits GAIP (RGS19) To Attenuate Dopamine D2 Receptor Signaling
Mol. Biol. Cell,
November 1, 2004;
15(11):
4926 - 4937.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Beom, D. Cheong, G. Torres, M. G. Caron, and K.-M. Kim
Comparative Studies of Molecular Mechanisms of Dopamine D2 and D3 Receptors for the Activation of Extracellular Signal-regulated Kinase
J. Biol. Chem.,
July 2, 2004;
279(27):
28304 - 28314.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Jeanneteau, J. Diaz, P. Sokoloff, and N. Griffon
Interactions of GIPC with Dopamine D2, D3 but not D4 Receptors Define a Novel Mode of Regulation of G Protein-coupled Receptors
Mol. Biol. Cell,
February 1, 2004;
15(2):
696 - 705.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Davila, Z. Yan, L. C. Craciun, D. Logothetis, and D. Sulzer
D3 Dopamine Autoreceptors Do Not Activate G-Protein-Gated Inwardly Rectifying Potassium Channel Currents in Substantia Nigra Dopamine Neurons
J. Neurosci.,
July 2, 2003;
23(13):
5693 - 5697.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Narita, K. Mizuo, H. Mizoguchi, M. Sakata, M. Narita, L. F. Tseng, and T. Suzuki
Molecular Evidence for the Functional Role of Dopamine D3 Receptor in the Morphine-Induced Rewarding Effect and Hyperlocomotion
J. Neurosci.,
February 1, 2003;
23(3):
1006 - 1012.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Schmitz, C. Schmauss, and D. Sulzer
Altered Dopamine Release and Uptake Kinetics in Mice Lacking D2 Receptors
J. Neurosci.,
September 15, 2002;
22(18):
8002 - 8009.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Rouge-Pont, A. Usiello, M. Benoit-Marand, F. Gonon, P. V. Piazza, and E. Borrelli
Changes in Extracellular Dopamine Induced by Morphine and Cocaine: Crucial Control by D2 Receptors
J. Neurosci.,
April 15, 2002;
22(8):
3293 - 3301.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K.-M. Kim, K. J. Valenzano, S. R. Robinson, W. D. Yao, L. S. Barak, and M. G. Caron
Differential Regulation of the Dopamine D2 and D3 Receptors by G Protein-coupled Receptor Kinases and beta -Arrestins
J. Biol. Chem.,
September 28, 2001;
276(40):
37409 - 37414.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|

|